| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |